OrbiMed Advisors IV Ltd's Net Worth

-$12.5 Million

Estimate Recalculated May 20, 2024 04:32PM EST

Who is OrbiMed Advisors IV Ltd?

OrbiMed Advisors IV Ltd does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., and Kinnate Biopharma Inc..

SEC CIK

OrbiMed Advisors IV Ltd's CIK is 0001966835

Past Insider Trading and Trends

2023 was OrbiMed Advisors IV Ltd's most active year for acquiring shares with 16 total transactions. OrbiMed Advisors IV Ltd's most active month to acquire stocks was the month of April. 2024 was OrbiMed Advisors IV Ltd's most active year for disposing of shares, totalling 4 transactions. OrbiMed Advisors IV Ltd's most active month to dispose stocks was the month of December. 2024 saw OrbiMed Advisors IV Ltd paying a total of $7,999,992.00 for 3,027,328 shares, this is the most they've acquired in one year. In 2024 OrbiMed Advisors IV Ltd cashed out on 2,582,884 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ArriVent Biopharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+143.25%
3.03M
$18.00
$3,999,996.00
5.14M
Jan 30
Form 3
—
0
—
—
0
No matching records found

Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.01M
—
—
0
Apr 3
Form 4
+21.20%
1.46M
$2.78
$4,086,234.61
8.35M
May 4 - May 5
Form 4
+10.11%
1.41M
$2.61
$3,673,900.83
15.3M
Apr 28 - May 2
Form 4
∞
1.1M
—
—
1.1M
Feb 17
Form 3
—
0
—
—
0
No matching records found